Idiopathic inflammatory muscle disease: Clinical aspects

Bailliere's Best Practice and Research in Clinical Rheumatology

Volumn 14, Issue 1, 2000, Pages 37-54

  Rider, Lisa G ^a   Miller, Frederick W ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Autoantibody; Classification; Myositis; Prognosis

Indexed keywords

AUTOANTIBODY;

CANCER; DERMATOMYOSITIS; DISEASE ACTIVITY; HUMAN; INFLAMMATORY DISEASE; MUSCLE DISEASE; MYOSITIS; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0034119420     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1053/berh.1999.0076     Document Type: Article

References (55)

1. Love L A, Leff R L, Fraser D D. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore). 70:1991;360-374.
2. Joffe M M, Love L A, Leff R L. Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. American Journal of Medicine. 94:1993;379-387.
3. Miller F W. Myositis-specific autoantibodies. Touchstones for understanding the inflammatory myopathies. Journal of the American Medical Association. 270:1993;1846-1849.
4. Callen J P. Relationship of cancer to inflammatory muscle disease. Dermatomyositis, polymyositis, and inclusion body myositis. Rheumatic Disease Clinics of North America. 20:1994;943-953.
5. Sigurgeirsson B, Lindelöf B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. New England Journal of Medicine. 326:1992;363-367.
6. Davis M D, Ahmed I. Ovarian malignancy in patients with dermatomyositis and polymyositis: a retrospective analysis of fourteen cases. Journal of the American Academy of Dermatology. 37:1997;730-733.
7. Whitmore S E, Rosenshein N B, Provost T T. Ovarian cancer in patients with dermatomyositis. Medicine (Baltimore). 73:1994;153-160.
8. Rider L G, Miller F W. Classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheumatic Disease Clinics of North America. 23:1997;619-655.
9. Nousari H C, Kimyai-Asadi A, Spegman D J. Paraneoplastic dermatomyositis presenting as erythroderma. Journal of the American Academy of Dermatology. 39:1998;653-654.
10. Leow Y H, Goh C L. Malignancy in adult dermatomyositis. International Journal of Dermatology. 36:1997;904-907.
11. Whitmore S E, Watson R, Rosenshein N B, Provost T T. Dermatomyositis sine myositis: association with malignancy. Journal of Rheumatology. 23:1996;101-105.
12. Bohan A, Peter J B, Bowman R L, Pearson C M. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore). 56:1977;255-286.
13. Stonecipher M R, Jorizzo J L, Monu J, Walker F, Sutej P G. Dermatomyositis with normal muscle enzyme concentrations. A single-blind study of the diagnostic value of magnetic resonance imaging and ultrasound. Archives of Dermatology. 130:1994;1294-1299.
14. Cosnes A, Amaudric F, Gherardi R. Dermatomyositis without muscle weakness. Long-term follow-up of 12 patients without systemic corticosteroids. Archives of Dermatology. 131:1995;1381-1385.
15. Park J H, Olsen N J, King L J. Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis. Arthritis and Rheumatism. 38:1995;68-77.
16. Rockerbie N R, Woo T Y, Callen J P, Giustina T. Cutaneous changes of dermatomyositis precede muscle weakness. Journal of the American Academy of Dermatology. 20:1989;629-632.
17. Euwer R L, Sontheimer R D. Amyopathic dermatomyositis (dermatomyositis sine myositis). Presentation of six new cases and review of the literature. Journal of the American Academy of Dermatology. 24:1991;959-966.
18. Dawkins M A, Jorizzo J L, Walker F O. Dermatomyositis: a dermatology-based case series. Journal of the American Academy of Dermatology. 38:1998;397-404.
19. Zieglschmid-Adams M E, Pandya A G, Cohen S B, Sontheimer R D. Treatment of dermatomyositis with methotrexate. Journal of the American Academy of Dermatology. 32:1995;754-757.
20. Stonecipher M R, Jorizzo J L, White W L, Walker F O, Prichard E. Cutaneous changes of dermatomyositis in patients with normal muscle enzymes: dermatomyositis sine myositis? Journal of the American Academy of Dermatology. 28:1993;951-956.
21. Rider L G, Miller F W, Targoff I N. A broadened spectrum of juvenile myositis. Myositis-specific autoantibodies in children. Arthritis and Rheumatism. 37:1994;1534-1538.
22. Hirakata M, Suwa A, Nagai S. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. Journal of Immunology. 162:1999;2315-2320.
23. Oddis C V, Sciurba F C, Elmagd K A, Starzl T E. Tacrolimus in refractory polymyositis with interstitial lung disease. Lancet. 353:1999;1762-1763.
24. Hausmanowa-Petrusewicz I, Kowalska-Oledzka E, Miller F W. Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis and Rheumatism. 40:1997;1257-1266.
25. Rider L G, Shamim E, Okada S. Genetic risk and protective factors for idiopathic inflammatory myopathy in Koreans and American whites: a tale of two loci. Arthritis and Rheumatism. 42:1999;1285-1290.
26. *0501. Human Immunology. 32:1991;235-240.
27. Crowe W E, Bove K E, Levinson J E, Hilton P K. Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis. Arthritis and Rheumatism. 25:1982;126-139.
28. Lundberg I E, Nyberg P. New developments in the role of cytokines and chemokines in inflammatory myopathies. Current Opinion in Rheumatology. 10:1998;521-529.
29. Plotz P H, Rider L G, Targoff I N. NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Annals of Internal Medicine. 122:1995;715-724.
30. Espada G, Confalone-Gregorian M, Ortiz Z. Serum autoantibodies in juvenile idiopathic inflammatory myopathies in a cohort of Argentine patients. Arthritis and Rheumatism. 40:1997;S140.
31. Kadoya A, Akahoshi T, Sekiyama N, Hosaka S, Kondo H. Cutaneous vasculitis in a patient with dermatomyositis without muscle involvement. Internal Medicine. 33:1994;809-812.
32. Quecedo E, Febrer I, Serrano G, Martinez-Aparicio A, Aliaga A. Partial lipdystrophy associated with juvenile dermatomyositis: report of two cases. Pediatric Dermatology. 13:1996;477-482.
33. Martini A, Ravelli A, Albani S. Recurrent juvenile dermatomyositis and cutaneous necrotizing arteritis with molecular mimicry between streptococcal type 5 M protein and human skeletal myosin. Journal of Pediatrics. 121:1992;739-742.
34. Love L A, Miller F W. Noninfectious environmental agents associated with myopathies. Current Opinion in Rheumatology. 5:1993;712-718.
35. Spencer C H, Hanson V, Singsen B H. Course of treated juvenile dermatomyositis. Journal of Pediatrics. 105:1984;399-408.
36. Miller F W. Classification and prognosis of inflammatory muscle disease. Rheumatic Disease Clinics of North America. 20:1994;811-826.
37. Calore E E, Cavaliere M J, Perez N M. Muscle pathology in juvenile dermatomyositis. Sao Paulo Medical Journal. 115:1997;1555-1559.
38. Garton M J, Isenberg D A. Clinical features of lupus myositis versus idiopathic myositis: a review of 30 cases. British Journal of Rheumatology. 36:1997;1067-1074.
39. Rider L G. Assessment of disease activity and its sequelae in children and adults with myositis. Current Opinion in Rheumatology. 8:1996;495-506.
40. Feldman B M, Ayling-Campos A, Luy L. Measuring disability in juvenile dermatomyositis: validity of the childhood health assessment questionnaire. Journal of Rheumatology. 22:1995;326-331.
41. Clarke A E, Bloch D A, Medsger T A Jr, Oddis C V. A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis. Arthritis and Rheumatism. 38:1995;1218-1224.
42. Lovell D J, Lindsley C, Rennebohm R. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. Arthritis and Rheumatism. 42:1999;2213-2219.
43. Josefson A, Romanus E, Carlsson J. A functional index in myositis. Journal of Rheumatology. 23:1996;1380-1384.
44. Villalba L, Hicks J E, Adams E M. Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens. Arthritis and Rheumatism. 41:1998;392-399.
45. Guzman J, Petty R E, Malleson P N. Monitoring disease activity in juvenile dermatomyositis: the role of von Willebrand factor and muscle enzymes. Journal of Rheumatology. 21:1994;739-743.
46. Pachman L M, Crawford S, Morrello F. MRI directed muscle biopsy for assessment of juvenile dermatomyositis response to therapy: comparison on initial and follow-up biopsies using a histological rating scale evaluating disease severity/chronicity. Arthritis and Rheumatism. 39:1996;S191.
47. Boer A, Summer R M, Turner M C. Magnetic resonance imaging detects occult tissue abnormalities in juvenile dermatomyositis. Arthritis and Rheumatism. 42:1999;5226.
48. Bloom B J, Tucker L B, Miller L C, Schaller J G. von Willebrand factor in juvenile dermatomyositis. Journal of Rheumatology. 22:1995;320-325.
49. Samsonov M Y, Nassonov E L, Tilz G P. Elevated serum levels of neopterin in adult patients with polymyositis/dermatomyositis. British Journal of Rheumatology. 36:1997;656-660.
50. Eisenstein D M, O'Gorman M RG, Pachman L M. Correlations between change in disease activity and changes in peripheral blood lymphocyte subsets in patients with juvenile dermatomyositis. Journal of Rheumatology. 24:1997;1830-1832.
51. Pachman L M, Mendez E, Kanuru R. Nailfold capillary studies in 50 untreated children with juvenile dermatomyositis. Arthritis and Rheumatism. 41:1998;S265.
52. Rider L G, Lachenbruch P, Rennebohm R. Identifying skin lesions in dermatomyositis: inter-rater reliability of a new cutaneous assessment tool. Arthritis and Rheumatism. 38:1996;S168.
53. Akira M, Hara H, Sakatani M. Interstitial lung disease in association with polymyositis-dermatomyositis: long-term follow-up CT evaluation in seven patients. Radiology. 210:1999;333-338.
54. Marguerie C, Bunn C C, Copier J. The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl. Medicine (Baltimore). 71:1992;327-336.
55. Miller, F, W, Inflammatory myopathies: polymyositis, dermatomyositis, and related conditions, Koopman, W, Arthritis and Allied Conditions: A Textbook of Rheumatology, Baltimore, Williams and Wilkins.